KR960001816B1 - Method for producing streptokinase and streptodornase - Google Patents

Method for producing streptokinase and streptodornase Download PDF

Info

Publication number
KR960001816B1
KR960001816B1 KR1019890015582A KR890015582A KR960001816B1 KR 960001816 B1 KR960001816 B1 KR 960001816B1 KR 1019890015582 A KR1019890015582 A KR 1019890015582A KR 890015582 A KR890015582 A KR 890015582A KR 960001816 B1 KR960001816 B1 KR 960001816B1
Authority
KR
South Korea
Prior art keywords
casein
streptokinase
enzyme
kfcc
cysteine
Prior art date
Application number
KR1019890015582A
Other languages
Korean (ko)
Other versions
KR910008134A (en
Inventor
현형환
문무상
김창호
허창업
강성구
정연수
안승후
이윤기
Original Assignee
제일제당주식회사
안시환
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제일제당주식회사, 안시환 filed Critical 제일제당주식회사
Priority to KR1019890015582A priority Critical patent/KR960001816B1/en
Publication of KR910008134A publication Critical patent/KR910008134A/en
Application granted granted Critical
Publication of KR960001816B1 publication Critical patent/KR960001816B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

New Streptococcus sp. CSKM 67881 (KFCC 10681) (I) and CSKL 10101 (KFCC 10682) (II) are screened from the mutants treated with NTG to Streptococcus sp. ATCC 12449. (I) or (II) is simultaneously cultivated at pH 6.8-7.2, 35-38 deg. C, 50-500 rpm agitation and 0.1-1 vvm aeration in the medium containing casein or Serratio peptidase hydrolyzed casein 0.75%, glutamine 0.01%, cysteine 0.005% and yeast extract 1-3% as nitrogen sources, over 8500 unit per milliliter of streptokinase and over 2000 unit per milliliter of streptodornase.

Description

발효에 의한 스트렙토키나제(streptokinase) 및 스트렙토도르나제(streptodornase)의 동시제조방법Simultaneous preparation of streptokinase and streptodornase by fermentation

본 발명은 스트렙토키나제 및 스트렙토도르나제를 고수율로 제조하는 방법에 관한 것으로, 포도당, 카제인 등을 주 원료로 한 영양배지에 스트렙토키나제와 스트렙토도르나제를 생산할 수 있는 미생물을 배양하고, 그 배양액중에 스트랩토키나제와 스트렙토도르나제를 축적시키는 것이다.The present invention relates to a method for producing streptokinase and streptodonase in high yield, and cultures microorganisms capable of producing streptokinase and streptodonase in a nutrient medium containing glucose and casein as main raw materials, and in the culture medium. It is the accumulation of straptokinase and streptodonase.

종래 발효에 의한 스트렙토키나제와 스트렙토도르나제의 제조방법으로는 미국특허 제2, 701, 227호에서와 같이 스트렙토코커스속(streptococcus. sp)을 영양배지에 배양한 후, 생선된 스트렙토키나제를 분리 정제하는 방법이 있으나, 이 방법은 발효완료액에 축적되는 스트렙토키나제의 역가(㎖당 1200~2000 단위)가 낮아 생산원가가 높은 단점이 있었다.As a method for producing streptokinase and streptodonase by conventional fermentation, the cultured Streptococcus sp is cultured in a nutrient medium as in US Pat. However, this method has a disadvantage in that the production cost is low because the titer (1200-2000 units per ml) of streptokinase accumulated in the fermentation broth is low.

따라서 본 발명은 종래의 이러한 발효에 의한 스트렙토키나제와 스트렙토도르나제의 생산방법을 개량하여 고역가의 두 효소를 동시에 제조할 수 있는 방법에 관한 것이다.Therefore, the present invention relates to a method for producing two enzymes of high titer at the same time by improving the production method of streptokinase and streptodonase by the conventional fermentation.

일반적으로 발효에서의 생산수율은 미생물의 생산역가와, 발효배지의 구성 및 배양조건 등에 의하여 좌우되며, 특히 발효배지의 조성은 미생물 생육에 필요한 물질 즉, 생육과 생산에 필수적인 여러가지 인자들이 적절히 조합되어야만 최대한의 효가를 얻을 수 있음은 당연하며, 스트렙토키나제 및 스트렙토도르나제의 발효에 있어서도 배지의 구성상 탄소원, 질소원 및 미량인자들의 균체의 성장 및 양 효소의 생산활동에 크게 영향을 미친다.In general, the yield of fermentation depends on the production capacity of microorganisms, the composition and culture conditions of fermentation broth, and especially the composition of fermentation broth must be appropriately combined with materials necessary for microbial growth, that is, various factors necessary for growth and production. Naturally, it is possible to obtain the maximum effect, and also in the fermentation of streptokinase and streptodonase, the composition of the medium greatly influences the growth of cells of carbon source, nitrogen source and trace factors and the production of both enzymes.

본 발명자들은 이러한 조건을 감안하여, 미생물 변이주에 의한 스트렙토키나제 및 스트렙토도르나제의 제조방법을 연구한 결과 특정변이주를 이용하여 특정한 조건, 즉 배양은 35℃~38℃, pH6.8~7.2, 교반속도 50~50rpm, 통기량 0.1~1vvm에서 탄소원, 질소원 기타 미량성분으로 구성된 배지중에서 단백질 분해효소에 의하여 분해된 카제인과 글루타민, 시스테인, 참치액기스를 적당량 첨가하여 줌으로써 스트렙토키나제 및 스트렙토도르나제를 고수율로 축적 생산할 수 있음을 발견하여 본 발명을 완성하였다. 본 발명에서 사용한 미생물 CSKM 67881, CSKL 10101은 한국종균협회(기타번호 KFCC10681, KFCC10682)에 기탁되어 있으며, ATCC 12449는 ATCC로부터 얻을 수 있다. 본 발명은 실시예에 의하여 좀더 상세하게 설명하면 다음과 같다.In view of these conditions, the present inventors studied the preparation method of streptokinase and streptodonase by microbial mutant strains. High yield of streptokinase and streptodonase by adding appropriate amounts of casein, glutamine, cysteine, and tuna extract decomposed by proteolytic enzymes in a medium consisting of carbon source, nitrogen source and other trace components at a speed of 50 to 50 rpm and aeration rate of 0.1 to 1 vmv The present invention was completed by discovering that it can be accumulated and produced. Microorganisms CSKM 67881, CSKL 10101 used in the present invention has been deposited with the Korean spawn association (other number KFCC10681, KFCC10682), ATCC 12449 can be obtained from ATCC. The present invention is described in more detail by the following examples.

[실시예 1]Example 1

사용균주 : 스트렙토코커스 변이주 CSKL 10101(KFCC 10682)Strains used: Streptococcus mutant strain CSKL 10101 (KFCC 10682)

전배양지 : 브레인 하트 인퓨전(Brain Heart Infusion : Difco Co.) 37g/ι, pH 7.0Pre-culture: Brain Heart Infusion (Difco Co.) 37g / ι, pH 7.0

종배지 :포도당 3%, 세라티옵펩티다제처리 카제인 0.5%, 황산마그네슘 0.1%, 인산제일칼륨 0.75%, 인산제이칼륨 0.2%, 효모엑기스 1%, 참치액기스1%, 글루타민 0.01%, 시스테인 0.005%, pH7.0Species medium: 3% glucose, 0.5% ceratioppeptidase-treated casein, 0.1% magnesium sulfate, 0.75% potassium phosphate, 0.2% potassium diphosphate, yeast extract 1%, 1% tuna extract, 0.01% glutamine, cysteine 0.005 %, pH7.0

발요배지 : 포도당5%, 세라티옵펩티다제처리 카제인 0.75%, 황산마그네슘 0.1%, 효모엑기스 1%, 참치액기스1%, 인산제일칼륨 0.75%, 인산제이칼륨 0.2%, 글루타민 0.01%, 효모엑기스 1%, 참치액기스1%, 시스테인 0.005%, pH7.0Foot medium: Glucose 5%, Ceratiopeptiptase-treated casein 0.75%, Magnesium sulfate 0.1%, Yeast extract 1%, Tuna extract 1%, Potassium phosphate 0.75%, Dipotassium phosphate 0.2%, Glutamine 0.01%, Yeast extract 1%, tuna extract 1%, cysteine 0.005%, pH7.0

배양방법 : 상기 조성의 전배양배지 25㎖를 250㎖ 삼각플라스크에 넣어 121℃에서 15분간 가압 살균한 다음 스크렙토코커스 변이주 CSKL 10101을 백금으로 식균하여 37℃에서 6시간 배양한다. 종배지1ι를 2.5ι소형 발효조에 넣고 121℃에서 15분간 가압 살균후 삼각플라스크의 전배양액 20㎖를 접종하여 37℃에서 교반속도 100rpm, 통기량 0.6vvm의 조건으로 통기 교반하여 6시간 종배양을 실시한다.Cultivation method: 25 ml of the pre-culture medium of the above composition in a 250 ml Erlenmeyer flask and autoclaved at 121 ° C. for 15 minutes, followed by incubating CSKL 10101 with S. a. The seed medium 1ι was placed in a 2.5ι small fermenter and then autoclaved at 121 ° C. for 15 minutes, and then inoculated with 20 ml of the pre-culture solution of the Erlenmeyer flask. Conduct.

발효배지에 세라티오펩티다제에 의하여 분해된 카제인을 농도별로 첨가하여 조제된 발효배지 25㎖씩을 5ι 발효조에 넣어 121℃에서 15분간 가압살균후 종배양액을 4% 용량으로 각각 접종하여 37℃의 조건에서 교반속도 100rpm, 통기량 0.6vvm의 조건으로 통기 교반하면서 10시간 동안 배양한다. 이때 배양액중의 균체농도는 600nm에서 스펙트로포토미터를 이용하여 흡광도(O. D.)를 측정하였으며 스트렙토키나제 및 스트렙토도르나제의 역가는 각가 로버방법( C. G. Rober and P. Kappus, Method of Enzymatic Analysis Vo1. 5. 433(1948))과 아키라 다케도방법(Akira Taketo and Yoriko Taket, Z. Naturforsch. 38 .107~111(1983))을 사용하였다.25 ml of fermented broth prepared by the addition of casein decomposed by Cerathio peptidase to the fermentation broth were added to a 5ι fermenter, and then autoclaved at 121 ° C. for 15 minutes, followed by inoculation of the seed culture solution with 4% volume, respectively. Under the conditions, incubation for 10 hours while aeration stirring under conditions of agitation speed 100rpm, aeration amount 0.6vvm. At this time, the cell concentration in the culture medium was measured for absorbance (OD) at 600 nm using a spectrophotometer, and the titers of streptokinase and streptodornase were determined by the C.R. 433 (1948)) and the Akira Takedo method (Akira Taketo and Yoriko Taket, Z. Naturforsch. 38.107-111 (1983)).

[표 1. 세라티옵펩티다제처리 카제인 농도별 효소역가]Table 1. Enzyme titers of ceratioppeptidase treated casein concentration]

Figure kpo00001
Figure kpo00001

[실시예 2]Example 2

실시예 1에 있어서 배지의 질소원으로서 카제인, 단백질분해효소에 의하여 분해처리된 카제인을 사용하여 농도변화, 처리시간변화, 단백질 분해효소 종류별 등에 따라 배양한 후의 효소역가의 결과를 표2, 표3, 표4등과 같다.In Example 1, the results of enzyme titer after culturing according to concentration change, treatment time change, protease type, and the like using casein and casein digested by casein as a nitrogen source of the medium were shown in Tables 2, 3, Table 4 and so on.

[표 2. 카제인 농도별 효소역가][Table 2. Enzyme titers by casein concentration]

Figure kpo00002
Figure kpo00002

[표 3. 세라티오펩티다제처리 시간별 효소역가]Table 3. Enzyme Titers According to Cerathiopeptidase Treatment Hours]

Figure kpo00003
Figure kpo00003

[표 4. 카제인처리 효소종류별 효소역가][Table 4. Enzyme Activity by Casein Enzyme Type]

Figure kpo00004
Figure kpo00004

실시예 3]Example 3

실시예 1에 있어서 발효배지중 효소분해 카제인 농도를 0.75%로 고정시킨 후 글루타민과 시스테인의 농도변화에 따라 배양한 후의 효소역가는 표 5와 같다.In Example 1, the enzyme titer after fermentation broth was fixed to 0.75% of enzyme degradation casein, and the enzyme titer after culturing according to the concentration change of glutamine and cysteine is shown in Table 5.

[표 5. 글루타민과 시스테인의 농도별 효소역가][Table 5. Glutamin and Cysteine Enzyme Activity by Concentration]

Figure kpo00005
Figure kpo00005

[실시예 4]Example 4

실시예 1에 있어서 배지중 효수분해 카제인 농도는 0.75%, 글루타민, 시스테인 농도는 각각 0.01%, 0.005%로 고정시킨 후 참치액기스의 농도를 변화시켜 배양한 후의 효소역가는 표 6과 같다.In Example 1, the enzyme hydrolysis casein concentration was 0.75%, glutamine and cysteine concentrations were fixed at 0.01% and 0.005%, respectively, and the enzyme titers after culturing with varying tuna extract concentrations are shown in Table 6.

[표 6. 참치엑기스 농도에 따른 효소역가][Table 6. Enzyme Activity According to Tuna Extract Concentration]

Figure kpo00006
Figure kpo00006

[실시예 5]Example 5

실시예 1에 있어서 발효배지중 효소분해 카제인 농도 0.75%, 글루타민 및 시스테인 농도는 각각 0.01% 및 0.005로 고정시킨 후 효모엑기스의 농도를 변화시켜 배양한 후의 효소역가는 표 7과 같다.In Example 1, enzyme enzyme casein concentration 0.75%, glutamine and cysteine concentrations in fermentation broth were fixed to 0.01% and 0.005, respectively, and the enzyme titers after culturing by changing the concentration of yeast extract are shown in Table 7.

[표 7. 효모엑기스 농도에 따른 효소역가][Table 7. Enzyme titer according to yeast extract concentration]

Figure kpo00007
Figure kpo00007

[실시예 6]Example 6

실시예 1에 있어서 교반속도와 통기량을 변화시켜 배양한 후의 효소역가는 표 8과 같다.In Example 1, the enzyme titer after culturing with varying agitation speed and aeration amount is shown in Table 8.

[표 8. 교반속도와 통기량의 변화에 따른 효소역가][Table 8. Enzyme Titers According to Changes in Agitation Rate and Aeration Rate]

Figure kpo00008
Figure kpo00008

Figure kpo00009
Figure kpo00009

Claims (3)

스트렙토코커스 변이주 KFCC 10681 또는 KFCC 10682를 영양배지에서 배양하여 고역가의 스트렙토키나제와 스트렙토도르나제를 생성함을 특징으로 하는 스트렙토키나제와 스트렙토도르나제의 제조방법.Streptococcus strain KFCC 10681 or KFCC 10682 is cultured in a nutrient medium to produce high titers of streptokinase and streptodonase. 제1항에 있어서, 영양배지가 질소원으로서 카제인 또는 단백질 분해효소에 의하여 분해된 카제인, 글루타민, 시스테인, 참치엑기스, 효모엑기스를 함유하는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the nutrient medium contains casein, glutamine, cysteine, tuna extract, and yeast extract digested by casein or protease as a nitrogen source. 제1항에 있어서, 배양조건중 교반속도를 50~500rpm, 통기량을 0.1~1vvm으로 하여 배양하는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the culture method comprises culturing at a stirring speed of 50 to 500 rpm and an aeration rate of 0.1 to 1 vvm.
KR1019890015582A 1989-10-28 1989-10-28 Method for producing streptokinase and streptodornase KR960001816B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890015582A KR960001816B1 (en) 1989-10-28 1989-10-28 Method for producing streptokinase and streptodornase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890015582A KR960001816B1 (en) 1989-10-28 1989-10-28 Method for producing streptokinase and streptodornase

Publications (2)

Publication Number Publication Date
KR910008134A KR910008134A (en) 1991-05-30
KR960001816B1 true KR960001816B1 (en) 1996-02-05

Family

ID=19291137

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890015582A KR960001816B1 (en) 1989-10-28 1989-10-28 Method for producing streptokinase and streptodornase

Country Status (1)

Country Link
KR (1) KR960001816B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020007232A (en) * 2001-08-10 2002-01-26 이병철 The production of streptokinase and streptodornase by fermentation method
KR100773126B1 (en) * 2006-08-25 2007-11-02 조선대학교산학협력단 Medium for mycelial growth using fomitopsis pinicola

Also Published As

Publication number Publication date
KR910008134A (en) 1991-05-30

Similar Documents

Publication Publication Date Title
CN102154160B (en) Strain capable of producing L-arginine and method for producing L-arginine by same
CN102417890B (en) Sinorhizobium meliloti and method for applying same for fermenting to produce manganese peroxidase
KR100339723B1 (en) Process for production of amide compounds using microorganism
JPS60244295A (en) Production of (+)- trans-cyclopropane carboxylic acid
KR960001816B1 (en) Method for producing streptokinase and streptodornase
JPS6322188A (en) Novel l-aminoacylase
KR940001307B1 (en) Microorganism for producing l-lysine
KR910007819B1 (en) Microorganism for producing streptokiuas & screptodprnase
KR0134131B1 (en) Cephalosporium which produces cephalosporin and process for cephalosporin
US3905866A (en) Process for production of L-lysine by fermentation
KR100303066B1 (en) Streptococcus sp. microorganism producing hyaluronic acid
KR0139589B1 (en) Microorganism and producing method of streptokinase and streptodornase
JPS6125358B2 (en)
KR820000523B1 (en) Process fpr producing l-alginine
KR930001389B1 (en) Process for producing l-arginine
KR102106479B1 (en) ANURINIBACILLUS MIGULANUS strain and use thereof
KR910007855B1 (en) Method for producing n-acetyl-l-glutamine
KR890002087B1 (en) Process for preparing gentamicin by fermentation
WO2000017379A2 (en) An l-lysine-producing microorganism and a method for producing l-lysine using said microorganism
SU767196A1 (en) Method of culturing lithic enzyme producents
KR920005976B1 (en) Method for preparation of l-glutamire
KR950007222B1 (en) Production of l-leucine by microorganism cultivation
KR0178085B1 (en) Mutant strains of the genus Tricosporonoides and preparation method of erythritol using the same
KR0162725B1 (en) Simultaneous production of streptokinase and streptodornase
KR930008970B1 (en) Vancomycin producing microorganism

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090203

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee